Form 4: Hartford Financial Services Group Executive Vice President Deepa Soni Reports Stock Option Grant
SEC Filing
Deepa Soni, Executive Vice President of Hartford Financial Services Group, reports the acquisition of stock options.
Summary
- Deepa Soni, an Executive Vice President at Hartford Financial Services Group, filed a Form 4 on February 29, 2024.
- The report details the grant of 15,522 stock options on February 27, 2024, with an exercise price of $95.74.
- These options vest in three equal installments annually, starting February 27, 2025.
- Soni also directly owns 26,897.993 shares of Hartford Financial Services Group common stock.
- The report also lists existing stock options with various exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, and the sentiment is neutral. It simply reports a stock option grant.
Positives
- The grant of stock options aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Industry Context
Stock option grants are a common form of executive compensation in the financial services industry, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Comparing Hartford's executive compensation structure to peers like Allstate, Progressive, and Travelers would provide a benchmark for assessing the competitiveness and appropriateness of the stock option grants.
- Analyzing the vesting schedules and exercise prices relative to industry averages can further illuminate the attractiveness of the compensation package.
- Reviewing proxy statements of comparable companies will provide detailed information on executive compensation practices.
Stakeholder Impact
- The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
- The grant incentivizes the executive to improve company performance, which could benefit all stakeholders.
Key Dates
| Date | Description |
|---|---|
| 02/23/2023 | One-third of options with exercise price $69.41 became exercisable. |
| 02/23/2024 | Options with exercise price $51.87 became fully exercisable; an additional one-third of options with exercise price $69.41 became exercisable. |
| 02/27/2024 | Date of the reported transaction: grant of 15,522 stock options with an exercise price of $95.74. |
| 02/28/2024 | One-third of options with exercise price $78.28 became exercisable. |
| 02/27/2025 | First vesting date for the newly granted options (1/3 of 15,522 options). |
| 02/23/2025 | Final vesting date for options with exercise price $69.41. |
| 02/28/2025 | Second vesting date for options with exercise price $78.28. |
| 02/27/2026 | Second vesting date for the newly granted options (1/3 of 15,522 options). |
| 02/28/2026 | Final vesting date for options with exercise price $78.28. |
| 02/27/2027 | Final vesting date for the newly granted options (1/3 of 15,522 options). |
| 02/23/2031 | Expiration date for options with exercise price $51.87. |
| 02/23/2032 | Expiration date for options with exercise price $69.41. |
| 02/28/2033 | Expiration date for options with exercise price $78.28. |
| 02/27/2034 | Expiration date for the newly granted options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.